Polymer-free drug-eluting stents for coronary artery disease-Reference-Cited by-同舟云学术

Polymer-free drug-eluting stents for coronary artery disease

Published:2018-02-20 Issue:3 Volume:31 Page:330-337
ISSN:0896-4327
Container-title:Journal of Interventional Cardiology
language:en
Short-container-title:J Interven Cardiol

Author:

Baquet Moritz¹²^ORCID,Jochheim David¹²,Mehilli Julinda¹²^ORCID

Affiliation:

1. Department of Cardiology; Munich University Clinic; Ludwig-Maximilian University; Munich Germany

2. DZHK (German Center for Cardiovascular Research); Partner Site Munich Heart Alliance; Munich Germany

Funder

Abbott Vascular and Edwards Lifescience

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,Radiology Nuclear Medicine and imaging

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/joic.12499/fullpdf

Reference42 articles.

1. A meta-analysis of 16 randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in patients with coronary artery disease;Schömig;J Am Coll Cardiol,2007

2. Stent polymers: do they make a difference;Rizas;Circ Cardiovasc Interv,2016

3. Acute thrombogenicity of a durable polymer everolimus-eluting stent relative to contemporary drug-eluting stents with biodegradable polymer coatings assessed ex vivo in a swine shunt model;Otsuka;JACC: Cardiovasc Interv,2015

4. Stent thrombogenicity early in high-risk interventional settings is driven by stent design and deployment and protected by polymer-drug coatings;Kolandaivelu;Circulation,2011

5. Clinical outcomes with bioabsorbable polymer- versus durable polymer-based drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis;Palmerini;J Am Coll Cardiol,2014

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CARDIAC ONCOLOGY: A MODERN VIEW ON THE PROBLEM OF CHOOSING AN OPTIMAL STRATEGY FOR THE TREATMENT OF CORONARY ARTERY DISEASE AND CANCER;Complex Issues of Cardiovascular Diseases;2023-09-25

2. Phytosynthesized nanomaterials for cardiovascular applications;Emerging Phytosynthesized Nanomaterials for Biomedical Applications;2023

3. Drug‐coated balloon for the treatment of small vessel disease: 9 months of angiographic results and 12 months of clinical outcomes of the PEPCAD China SVD study;Catheterization and Cardiovascular Interventions;2022-12-08

4. A prospective, multicentre first-in-man study of the polymer-free ultrathin-strut BIOrapid stent (BIOVITESSE);EuroIntervention;2022-06

5. Polymer-free biolimus-coated stents versus ultrathin-strut biodegradable polymer sirolimus-eluting stents: two-year outcomes of the randomised SORT OUT IX trial;EuroIntervention;2022-06